Analysis of Status Quo of Clinical Pathway in “Paid by Disease Types” in China

FENG Shuai,SHI Lu-wen
DOI: https://doi.org/10.6039/j.issn.1001-0408.2012.18.01
2012-01-01
Abstract:OBJECTIVE: To explore the status quo of clinical pathway in "paid by disease types" in China, and to provide reference for the further implementation of related policy. METHODS: After a literature review, questionnaire survey, field investigation and typical cases analysis, the supporting condition of clinical pathway in "paid by disease types" in China was studied. RESULTS&CONCLUSION: Up to Sept. 2010, uniform and standard disease type clinical pathway haven’t formed in most provinces in China. Ministry of Health and provincial health authorities mainly develop clinical pathways as a guide or reference for the formulation of clinical way in medical institutions, so they focus on the planning of process, rather than limit for the specification of drugs or supplies products. Medical institutions develop their own clinical pathways, and formulate the limit for the specification of drugs and supplies products, considering the technology, cost and some other factors.
What problem does this paper attempt to address?